SCHEMBL12424110

SCHEMBL12424110

Cc1ccccc1-c1onc(-c2ccc(Cl)cc2Cl)c1C(O)c1cccnc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.43
ATM Q13315 1/20 0.42
CYP3A4 P08684 1/20 0.39
PDE10A Q9Y233 1/20 0.39
KCNA5 P22460 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ALDH1A1 P00352 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
DPP4 P27487 1/20 0.37
LMNA P02545 2/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
ROS1 P08922 1/20 0.37
BRD4 O60885 1/20 0.36
MAPT P10636 2/20 0.36
TP53 P04637 1/20 0.36
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2197781 0.91 KCNA5 (0.45) GAAATMCYP3A4KCNA5NPC1
SCHEMBL2194938 0.87 SMN1; SMN2 (0.42) ATMCYP3A4KCNA5NPC1RAB9A
SCHEMBL2198569 0.86 BRD4 (0.40) GAAATMCYP3A4PDE10AKCNA5
SCHEMBL2198613 0.86 NPC1 (0.41) ATMCYP3A4PDE10AKCNA5NPC1
SCHEMBL2198005 0.86 HSD11B1 (0.40) ATMCYP3A4KCNA5NPC1RAB9A
SCHEMBL2195309 0.84 KCNA5 (0.45) ATMCYP3A4KCNA5NPC1RAB9A
SCHEMBL2197442 0.83 NPC1 (0.41) GAAATMCYP3A4PDE10AKCNA5
SCHEMBL2200424 0.82 ATM (0.44) ATMKCNA5NPC1RAB9ARXFP1
SCHEMBL2197313 0.82 TSHR (0.42) GAAATMCYP3A4PDE10AKCNA5
SCHEMBL3124272 0.81 ATM (0.39) GAAATMCYP3A4PDE10AKCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-7977341-B2 For crops; 3-(2,6-Dichlorophenyl)-4-[(3-pyridyl)hydroxymethyl]-5-trimethylsilylisoxazole for example SYNGENTA LIMITED (GB) 2011-07-12 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-20080096843-A1 Substituted Isoxazoles as Fungicides SYNGENTA LIMITED (GB) 2008-04-24 US disclosed
US-7338967-B2 Substituted isoxazoles as fungicides SYNGENTA LIMITED (GB) 2008-03-04 US disclosed
US-7338967-B2 Substituted isoxazoles as fungicides SYNGENTA LIMITED (GB) 2008-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096843-A1 Substituted Isoxazoles as Fungicides CYP4X1, CYP51A1, CYP3A7 GAA 860/4885ATM 3589/4885CYP3A4 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.